Dec 18 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LTD - MESOBLAST UPDATE ON COVID-19 ARDS TRIAL-MSB.AX
* MESOBLAST LTD - DSMB REPORTED TRIAL IS NOT LIKELY TO MEET 30-DAY MORTALITY REDUCTION ENDPOINT AT PLANNED 300 PATIENT ENROLMENT
Dec 18 (Reuters) - Mesoblast Ltd MSB.AX :
* MESOBLAST LTD - MESOBLAST UPDATE ON COVID-19 ARDS TRIAL-MSB.AX
* MESOBLAST LTD - DSMB REPORTED TRIAL IS NOT LIKELY TO MEET 30-DAY MORTALITY REDUCTION ENDPOINT AT PLANNED 300 PATIENT ENROLMENT